Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hypoglycemia
Phenotype C0011847|diabetes
Sentences 306
PubMedID- 21193625 A large cohort study suggested that among older adults with type 2 diabetes, a history of severe hypoglycemia was associated with greater risk of dementia (174).
PubMedID- 24023652 These findings agree with the results of previous studies [4], [14] where the neuroendocrine response of vasopressin to hypoglycaemia was enhanced in patients with type 1 diabetes compared to healthy subjects.
PubMedID- 21195501 Self-reported experience of hypoglycemia among adults with type 2 diabetes mellitus (exhype).
PubMedID- 26417415 Thus, further studies are required regarding fear of hypoglycemia in patients with type 2 diabetes mellitus.
PubMedID- 26061690 The primary aim of this systematic review was to explore the incidence and prevalence of hypoglycaemia in people with type 2 diabetes within a general population-based setting.
PubMedID- 21680991 Recognition, prevention, and proactive management of hypoglycemia in patients with type 1 diabetes mellitus.
PubMedID- 22401876 Recurrent episodes of hypoglycemia in patients with diabetes are often associated with the ongoing treatment regimen.
PubMedID- 26252486 Among adults with diabetes, the weighted number of ed visits for hypoglycemia decreased from 308,232 in 2006 to 282,254 visits in 2011 (p = 0.0499) (table 1), and the weighted number of ed visits for hyperglycemic crisis increased from 129,752 in 2006 to 174,998 in 2011 (p < 0.001).
PubMedID- 26019877 Although the causes of hypoglycemia in patients with diabetes are multifactorial, there may be some explanations for the association of severe hypoglycemia with depression in patients with type 2 diabetes.
PubMedID- 23926410 Nateglinide is effective for diabetes mellitus with reactive hypoglycemia in a child with a compound heterozygous abcc8 mutation.
PubMedID- 25589828 Therefore, the identification of measures to prevent hypoglycemia in patients with type 2 diabetes is needed urgently.
PubMedID- 23589542 Consequently the workgroup defines iatrogenic hypoglycemia in patients with diabetes as all episodes of an abnormally low plasma glucose concentration that expose the individual to potential harm.
PubMedID- 24204343 Indeed, poor cognitive function also increases the risk of severe hypoglycemia in patients with type 2 diabetes (punthakee et al., 2012).
PubMedID- 25937182 Appropriate risk management plans should be developed to prevent the occurrence of severe hypoglycemia in patients with type 2 diabetes in taiwan.
PubMedID- 21346182 The hfs-ii is a reliable and valid measure of the fear of hypoglycemia in adults with type 1 diabetes, and factor analyses and irt support the two separate subscales of the survey.
PubMedID- 23801814 A case of type 1 diabetes with nocturnal hypoglycemia after desensitization therapy for insulin allergy.
PubMedID- 23067027 Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues bid in outpatient settings.
PubMedID- 19896233 Aims: to compare total costs and risk of hypoglycemia in patients with type 2 diabetes (t2d) initiated on nph insulin versus glargine in a real-world setting.
PubMedID- 22584135 Therefore, our data do not support the hypothesis that severe hypoglycemia in patients with type 1 diabetes increases the risk of cvd.
PubMedID- 24794703 Background: insulin analogues have been developed to reduce the risk of hypoglycaemia in patients with diabetes who require insulin-based treatment, but their effect on this endpoint in patients with type 1 diabetes complicated by recurrent severe hypoglycaemia is unknown.
PubMedID- 22892724 Here, we tested the hypothesis that this region is less activated during hypoglycemia in subjects with type 1 diabetes (t1dm) and hypoglycemia unawareness relative to controls.
PubMedID- 25855340 Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial.
PubMedID- 23807921 In a 26-week randomized, parallel, treat to target trial comparing insulin detemir with neutral protamine hagedorn (nph) insulin as add-on therapy to oral glucose lowering drugs in insulin-naïve population with type 2 diabetes, the risk of all hypoglycemia with insulin detemir was reduced by 47% (p<0.001) and nocturnal hypoglycemia by 55% (p<0.001) when compared with nph insulin [10].
PubMedID- 25125745 The mechanisms responsible for intensive therapy causing increased hypoglycemia in patients with diabetes have been extensively investigated.
PubMedID- 25961051 A nurse-managed protocol focusing on carbohydrate intake reduced the incidence of hypoglycemia in patients with diabetes receiving subcutaneous insulin in hospital.
PubMedID- 26354059 This study is the first to examine electrolyte profiles during severe hypoglycemia in patients with type 2 diabetes in clinical practice.
PubMedID- 21231863 The objective of this study was to compare healthcare utilization, costs, adherence, and hypoglycemia rates in patients with type 2 diabetes mellitus (t2dm) initiating rapid-acting insulin analog (raia) using prefilled pen versus vial/syringe.
PubMedID- 24223662 This regimen is more efficient and reduces the incidence of hypoglycemia in patients with type 2 diabetes, indicating that it is likely to be a promising treatment strategy for the disease.
PubMedID- 22371161 Continuous subcutaneous insulin infusion (csii, or insulin pump therapy) reduces hba1c levels and hypoglycaemia in patients with type 1 diabetes mellitus (t1dm) compared with multiple daily insulin injections (mdi).
PubMedID- 23075070 In people with insulin-treated type 2 diabetes, recall of severe hypoglycaemia is similarly robust over a period of one year[30] but the reliability of recall of mild hypoglycaemia has not been examined and is unlikely to be preserved.
PubMedID- 26019290 We have also found that performing one or several short sprints is protective against hypoglycemia in individuals with type 1 diabetes (guelfi et al.
PubMedID- 23537420 Nocturnal continuous glucose monitoring: accuracy and reliability of hypoglycemia detection in patients with type 1 diabetes at high risk of severe hypoglycemia.
PubMedID- 20456169 Some therapeutic regimens are associated with a significantly increased risk of hypoglycaemia in patients with type 2 diabetes (1,3,4,19).
PubMedID- 22738801 hypoglycemia in patients with type 2 diabetes from india and malaysia treated with sitagliptin or a sulfonylurea during ramadan: a randomized, pragmatic study.
PubMedID- 24736487 Aim: the aim of this paper was to compare the predictive value of glycated hemoglobin (a1c) and glucose variability (gv) in the risk of hypoglycemia in patients with type 1 diabetes (t1d).
PubMedID- 22891254 hypoglycemia in diabetes is generally the result of the interplay of therapeutic hyperinsulinemia and compromised physiological and behavioral defenses against falling plasma glucose concentrations (1).
PubMedID- 23881546 Severe hypoglycemia in patients with diabetes is associated with increased risk of adverse cardiovascular events and death.
PubMedID- 20929999 The epinephrine response to hypoglycemia in patients with type 1 diabetes with hypoglycemia unawareness was greater after the use of real-time cgm with low glucose alarms than with standard medical therapy alone.
PubMedID- 24185751 Bariatric teams performing lsg for morbid obesity should heighten their sensitivity to postoperative hypoglycemia, even in patients with type 2 diabetes mellitus.
PubMedID- 21984582 During hypoglycemia, patients with type 1 diabetes exhibit less deactivation than control subjects.
PubMedID- 22563248 Sulfonylurea therapy, which increases insulin output from the pancreas, is one of the key contributors to hypoglycemia in patients with type 2 diabetes who are early in the progression of the disease.
PubMedID- 22965294 A decrease in time spent in hypoglycaemia in patients with well-controlled diabetes with substantially lower mean hba1c has been previously reported [10]; however, this is the first report of a concomitant decrease in hba1c and time spent in hypoglycaemia in participants with less well controlled diabetes using cgm.
PubMedID- 21747831 Recently, it was demonstrated that during spontaneous hypoglycemia in patients with type 1 diabetes, qtc interval can be moderately increased [44], whereas glucose-qtc association is reported to differ among individuals with type 1 diabetes.
PubMedID- 23173147 In the article, incidence of severe hypoglycemia in patients with type 1 diabetes was 11.5 in the first period and 23.4 episodes/100,000 person-years in the second period.
PubMedID- 23855268 Caffeine intake has also been proposed to increase symptomatic warning signs of hypoglycemia in patients with type 1 diabetes and elevate blood glucose levels in patients with type 2 diabetes.
PubMedID- 26321136 Increased secretion of glp-1 may have caused reactive hypoglycaemia in patients with type 2 diabetes undergoing gastric surgery.
PubMedID- 23900589 To investigate the relationship between hba1c level and hypoglycemia among patients with type 2 diabetes treated with glucose-lowering medications in a usual care setting, we analyzed data from the diabetes study of northern california (distance) survey.
PubMedID- 23630300 All transplant recipients had long-standing c-peptide–negative type 1 diabetes complicated by hypoglycemia unawareness and frequent severe hypoglycemia events.
PubMedID- 23434929 Paradoxically, somatostatin concentrations are elevated at baseline and rise further during hypoglycemia in patients with type 1 diabetes mellitus who are on exogenous insulin (19).
PubMedID- 25949827 Cardiac implications are also related to hypoglycaemia in patients with diabetes [23].

Page: 1 2 3 4 5 6 7